Ionis to present at upcoming investor conferences
05/26/2021 - 07:05 AM
CARLSBAD, Calif. , May 26, 2021 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will present a company overview at the following virtual investor conferences:
William Blair 41st Annual Growth Stock Conference on Tuesday, June 1, 2021 Goldman Sachs 42nd Annual Global Healthcare Conference on Wednesday, June 9, 2021 Nasdaq 44th Investor Conference on Tuesday, June 15, 2021 BMO Biopharma Day: Spotlight on Rare Disease and Ophthalmology on Tuesday, June 22, 2021 The above listed dates are subject to change. Details on presentation times or changes to presentation dates can be found on the Company's website. Please check www.ionispharma.com for the latest information.
A live webcast of the presentations will be available on the Investors & Media section of the Ionis website. The replays will be available within 48 hours and will be archived for a limited time.
About Ionis Pharmaceuticals For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing standards of care with its novel antisense technology. Ionis currently has three marketed medicines and a premier late-stage pipeline highlighted by industry-leading neurological and cardiometabolic franchises. Our scientific innovation began and continues with the knowledge that sick people depend on us, which fuels our vision of becoming one of the most successful biotechnology companies.
To learn more about Ionis visit www.ionispharma.com and follow us on Twitter @ionispharma.
http://www.prnewswire.com/news-releases/ionis-to-present-at-upcoming-investor-conferences-301299234.html
SOURCE Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals Inc
IONS Rankings
#2013 Ranked by Stock Gains
IONS Stock Data
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Tags
Health Technology, Biotechnology, Manufacturing, Pharmaceutical Preparation Manufacturing
Country
US
City
Carlsbad
About IONS
ionis pharmaceuticals, inc., located in the north san diego county city of carlsbad, was founded in 1989 to create advanced, novel medicines to treat complex and challenging diseases. we are the pioneer in the discovery and development of antisense drugs with more than 1300 patents. ionis is a challenging, motivating and rewarding environment designed to foster innovation and scientific excellence. our founding goals have changed little in over 27 years and our success is a direct result of our outstanding employees. we are interested in bringing together individuals with different skill sets into this creative environment to be part of a productive team. join us and experience our unique culture while you develop and expand your career. for more information about ionis and to apply for an open position, please visit our website: www.ionispharma.com.
